{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:05:23Z","timestamp":1789621523811,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,4]]},"DOI":"10.7759\/cureus.61639","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T10:46:30Z","timestamp":1717497990000},"source":"Crossref","is-referenced-by-count":3,"title":["Genetic Rearrangements in Different Salivary Gland Tumors: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Elham","family":"Albalawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411930040050201","article-title":"Current status of histogenetic and morphogenetic concepts of salivary gland tumorigenesis","volume":"4","author":"Dardick I","year":"1993","unstructured":"Dardick I, Burford-Mason AP. Current status of histogenetic and morphogenetic concepts of salivary gland tumorigenesis. Crit Rev Oral Biol Med. 1993, 4:639-77. 10.1177\/10454411930040050201","journal-title":"Crit Rev Oral Biol Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153910","article-title":"An overview on the histogenesis and morphogenesis of salivary gland neoplasms and evolving diagnostic approaches","volume":"13","author":"Iyer J","year":"2021","unstructured":"Iyer J, Hariharan A, Cao UM, et al.. An overview on the histogenesis and morphogenesis of salivary gland neoplasms and evolving diagnostic approaches. Cancers (Basel). 2021, 13:3910. 10.3390\/cancers13153910","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.08.017","article-title":"Don't stop the champions of research now: a brief history of head and neck pathology developments","volume":"95","author":"Thompson LD","year":"2020","unstructured":"Thompson LD, Lewis JS Jr, Sk\u00e1lov\u00e1 A, Bishop JA. Don't stop the champions of research now: a brief history of head and neck pathology developments. Hum Pathol. 2020, 95:1-23. 10.1016\/j.humpath.2019.08.017","journal-title":"Hum Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-017-0790-5","article-title":"Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumours of the ear","volume":"11","author":"Thompson LD","year":"2017","unstructured":"Thompson LD. Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumours of the ear. Head Neck Pathol. 2017, 11:78-87. 10.1007\/s12105-017-0790-5","journal-title":"Head Neck Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-020-01140-4","article-title":"Salivary gland cancer in the era of routine next-generation sequencing","volume":"14","author":"Todorovic E","year":"2020","unstructured":"Todorovic E, Dickson BC, Weinreb I. Salivary gland cancer in the era of routine next-generation sequencing. Head Neck Pathol. 2020, 14:311-20. 10.1007\/s12105-020-01140-4","journal-title":"Head Neck Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5801","article-title":"Prognostic risk factor of major salivary gland carcinomas and survival prediction model based on random survival forests","volume":"12","author":"Chen Y","year":"2023","unstructured":"Chen Y, Li G, Jiang W, et al.. Prognostic risk factor of major salivary gland carcinomas and survival prediction model based on random survival forests. Cancer Med. 2023, 12:10899-907. 10.1002\/cam4.5801","journal-title":"Cancer Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s1368-8375(02)00003-9","article-title":"Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers","volume":"38","author":"Darling MR","year":"2002","unstructured":"Darling MR, Schneider JW, Phillips VM. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol. 2002, 38:641-5. 10.1016\/s1368-8375(02)00003-9","journal-title":"Oral Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.adoms.2021.100079","article-title":"Polymorphous adenocarcinoma transforming to adenoid cystic carcinoma - a case report","volume":"3","author":"Anjali AK","year":"2021","unstructured":"Anjali AK, Tamgadge S, Pereira T, Vidhale RG, Sudhamani S. Polymorphous adenocarcinoma transforming to adenoid cystic carcinoma - a case report. Adv Oral Maxillofac Surg. 2021, 3:100079. 10.1016\/j.adoms.2021.100079","journal-title":"Adv Oral Maxillofac Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-023-08110-w","article-title":"Salivary gland pathologies: evolution in classification and association with unique genetic alterations","volume":"280","author":"\u017burek M","year":"2023","unstructured":"\u017burek M, Fus \u0141, Niemczyk K, Rzepakowska A. Salivary gland pathologies: evolution in classification and association with unique genetic alterations. Eur Arch Otorhinolaryngol. 2023, 280:4739-50. 10.1007\/s00405-023-08110-w","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001688","article-title":"Salivary mucinous adenocarcinoma is a histologically diverse single entity with recurrent AKT1 E17K mutations: clinicopathologic and molecular characterization with proposal for a unified classification","volume":"45","author":"Rooper LM","year":"2021","unstructured":"Rooper LM, Argyris PP, Thompson LD, et al.. Salivary mucinous adenocarcinoma is a histologically diverse single entity with recurrent AKT1 E17K mutations: clinicopathologic and molecular characterization with proposal for a unified classification. Am J Surg Pathol. 2021, 45:1337-47. 10.1097\/PAS.0000000000001688","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01471-4","article-title":"Nkx3.1 expression in salivary gland \u201cintraductal\u201d papillary mucinous neoplasm: a low-grade subtype of salivary gland mucinous adenocarcinoma","volume":"16","author":"Nakaguro M","year":"2022","unstructured":"Nakaguro M, Sadow PM, Hu R, et al.. Nkx3.1 expression in salivary gland \u201cintraductal\u201d papillary mucinous neoplasm: a low-grade subtype of salivary gland mucinous adenocarcinoma. Head Neck Pathol. 2022, 16:1114-23. 10.1007\/s12105-022-01471-4","journal-title":"Head Neck Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001080","article-title":"Intraductal papillary mucinous neoplasms of minor salivary glands with AKT1 p.Glu17Lys mutation","volume":"42","author":"Agaimy A","year":"2018","unstructured":"Agaimy A, Mueller SK, Bumm K, et al.. Intraductal papillary mucinous neoplasms of minor salivary glands with AKT1 p.Glu17Lys mutation. Am J Surg Pathol. 2018, 42:1076-82. 10.1097\/PAS.0000000000001080","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041236","article-title":"Histopathological aspects of the prognostic factors for salivary gland cancers","volume":"15","author":"Nishida H","year":"2023","unstructured":"Nishida H, Kusaba T, Kawamura K, Oyama Y, Daa T. Histopathological aspects of the prognostic factors for salivary gland cancers. Cancers (Basel). 2023, 15:1236. 10.3390\/cancers15041236","journal-title":"Cancers (Basel)"},{"key":"ref14","article-title":"Malignant Tumors of the Palate","author":"Young A","year":"2024","unstructured":"Young A, Okuyemi OT. Malignant Tumors of the Palate. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35722","article-title":"Myoepithelial carcinoma ex pleomorphic adenoma of the submandibular gland: a case report","volume":"15","author":"Syrnioti G","year":"2023","unstructured":"Syrnioti G, Syrnioti A, Abdullah A, Lui X, Mendoza E. Myoepithelial carcinoma ex pleomorphic adenoma of the submandibular gland: a case report. Cureus. 2023, 15:e35722. 10.7759\/cureus.35722","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4274\/MMJ.galenos.2022.63139","article-title":"Heterogeneity of genetic landscapes in salivary gland tumors and their critical roles in current management","volume":"37","author":"Yousaf A","year":"2022","unstructured":"Yousaf A, Sulong S, Abdullah B, Lazim NM. Heterogeneity of genetic landscapes in salivary gland tumors and their critical roles in current management. Medeni Med J. 2022, 37:194-202. 10.4274\/MMJ.galenos.2022.63139","journal-title":"Medeni Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051390","article-title":"Dominant gene expression profiles define adenoid cystic carcinoma (ACC) from different tissues: validation of a gene signature classifier for poor survival in salivary gland ACC","volume":"15","author":"Brayer KJ","year":"2023","unstructured":"Brayer KJ, Kang H, El-Naggar AK, et al.. Dominant gene expression profiles define adenoid cystic carcinoma (ACC) from different tissues: validation of a gene signature classifier for poor survival in salivary gland ACC. Cancers (Basel). 2023, 15:1390. 10.3390\/cancers15051390","journal-title":"Cancers (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092263","article-title":"Development and characterization of MYB-NFIB fusion expression in adenoid cystic carcinoma","volume":"14","author":"Humtsoe JO","year":"2022","unstructured":"Humtsoe JO, Kim HS, Jones L, et al.. Development and characterization of MYB-NFIB fusion expression in adenoid cystic carcinoma. Cancers (Basel). 2022, 14:2263. 10.3390\/cancers14092263","journal-title":"Cancers (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-0194-3","article-title":"ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma","volume":"9","author":"Andersson MK","year":"2020","unstructured":"Andersson MK, Mangiapane G, Nevado PT, et al.. ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma. Oncogenesis. 2020, 9:5. 10.1038\/s41389-020-0194-3","journal-title":"Oncogenesis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23641","article-title":"Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes","volume":"9","author":"Frerich CA","year":"2018","unstructured":"Frerich CA, Brayer KJ, Painter BM, Kang H, Mitani Y, El-Naggar AK, Ness SA. Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes. Oncotarget. 2018, 9:7341-58. 10.18632\/oncotarget.23641","journal-title":"Oncotarget"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2021.03.008","article-title":"SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets","volume":"23","author":"Freiberger SN","year":"2021","unstructured":"Freiberger SN, Brada M, Fritz C, et al.. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets. Neoplasia. 2021, 23:473-87. 10.1016\/j.neo.2021.03.008","journal-title":"Neoplasia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s44178-023-00030-3","article-title":"Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy","volume":"2","author":"Lin Q-Q","year":"2023","unstructured":"Lin Q-Q, Sun J-L, Wang F, Zhang H-Z, Zhou G, Xi Q. Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy. Holist Integ Onco. 2023, 2:7. 10.1007\/s44178-023-00030-3","journal-title":"Holist Integ Onco"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1192","article-title":"Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets","volume":"27","author":"Ferrarotto R","year":"2021","unstructured":"Ferrarotto R, Mitani Y, McGrail DJ, et al.. Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets. Clin Cancer Res. 2021, 27:852-64. 10.1158\/1078-0432.CCR-20-1192","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2010.02.001","article-title":"Expression of c-kit and slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma","volume":"46","author":"Tang Y","year":"2010","unstructured":"Tang Y, Liang X, Zheng M, Zhu Z, Zhu G, Yang J, Chen Y. Expression of c-kit and slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol. 2010, 46:311-6. 10.1016\/j.oraloncology.2010.02.001","journal-title":"Oral Oncol"},{"key":"ref26","article-title":"Surgical Pathology of the Salivary Glands","author":"Ellis GL","year":"1991","unstructured":"Ellis GL, Auclair PL, Gnepp DR. Surgical Pathology of the Salivary Glands. WB Saunders, Philadelphia, PA; 1991."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0463","article-title":"Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance","volume":"16","author":"Mitani Y","year":"2010","unstructured":"Mitani Y, Li J, Rao PH, et al.. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010, 16:4722-31. 10.1158\/1078-0432.CCR-10-0463","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2985","article-title":"A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets","volume":"5","author":"Gao R","year":"2014","unstructured":"Gao R, Cao C, Zhang M, et al.. A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets. Oncotarget. 2014, 5:12528-42. 10.18632\/oncotarget.2985","journal-title":"Oncotarget"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3502","article-title":"An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma","volume":"48","author":"Drier Y","year":"2016","unstructured":"Drier Y, Cotton MJ, Williamson KE, et al.. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016, 48:265-72. 10.1038\/ng.3502","journal-title":"Nat Genet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13952","article-title":"Management of salivary gland carcinomas - a review","volume":"8","author":"Wang X","year":"2017","unstructured":"Wang X, Luo Y, Li M, Yan H, Sun M, Fan T. Management of salivary gland carcinomas - a review. Oncotarget. 2017, 8:3946-56. 10.18632\/oncotarget.13952","journal-title":"Oncotarget"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2014.04.008","article-title":"Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers","volume":"50","author":"Stenman G","year":"2014","unstructured":"Stenman G, Persson F, Andersson MK. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers. Oral Oncol. 2014, 50:683-90. 10.1016\/j.oraloncology.2014.04.008","journal-title":"Oral Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0637","article-title":"Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer","volume":"22","author":"Dalin MG","year":"2016","unstructured":"Dalin MG, Desrichard A, Katabi N, et al.. Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer. Clin Cancer Res. 2016, 22:4623-33. 10.1158\/1078-0432.CCR-16-0637","journal-title":"Clin Cancer Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.8612","article-title":"Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands","volume":"25","author":"Agulnik M","year":"2007","unstructured":"Agulnik M, Cohen EW, Cohen RB, et al.. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol. 2007, 25:3978-84. 10.1200\/JCO.2007.11.8612","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00545","article-title":"Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma","volume":"37","author":"Takahashi H","year":"2019","unstructured":"Takahashi H, Tada Y, Saotome T, et al.. Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma. J Clin Oncol. 2019, 37:125-34. 10.1200\/JCO.18.00545","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182880d5a","article-title":"PIK3CA mutations and PTEN loss in salivary duct carcinomas","volume":"37","author":"Griffith CC","year":"2013","unstructured":"Griffith CC, Seethala RR, Luvison A, Miller M, Chiosea SI. PIK3CA mutations and PTEN loss in salivary duct carcinomas. Am J Surg Pathol. 2013, 37:1201-7. 10.1097\/PAS.0b013e3182880d5a","journal-title":"Am J Surg Pathol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.605","article-title":"Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer","volume":"106","author":"Ettl T","year":"2012","unstructured":"Ettl T, Baader K, Stiegler C, et al.. Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer. Br J Cancer. 2012, 106:719-26. 10.1038\/bjc.2011.605","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18173","article-title":"Somatic mutations in salivary duct carcinoma and potential therapeutic targets","volume":"8","author":"Khoo TK","year":"2017","unstructured":"Khoo TK, Yu B, Smith JA, et al.. Somatic mutations in salivary duct carcinoma and potential therapeutic targets. Oncotarget. 2017, 8:75893-903. 10.18632\/oncotarget.18173","journal-title":"Oncotarget"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.03.004","article-title":"The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement","volume":"88","author":"Dogan S","year":"2019","unstructured":"Dogan S, Ng CK, Xu B, et al.. The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement. Hum Pathol. 2019, 88:66-77. 10.1016\/j.humpath.2019.03.004","journal-title":"Hum Pathol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda M","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, et al.. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007, 448:561-6. 10.1038\/nature05945","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/nature15258","article-title":"Alternative transcription initiation leads to expression of a novel ALK isoform in cancer","volume":"526","author":"Wiesner T","year":"2015","unstructured":"Wiesner T, Lee W, Obenauf AC, et al.. Alternative transcription initiation leads to expression of a novel ALK isoform in cancer. Nature. 2015, 526:453-7. 10.1038\/nature15258","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0351-4","article-title":"Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes","volume":"33","author":"Sebastiao AP","year":"2020","unstructured":"Sebastiao AP, Xu B, Lozada JR, et al.. Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes. Mod Pathol. 2020, 33:65-73. 10.1038\/s41379-019-0351-4","journal-title":"Mod Pathol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehpc.2021.200496","article-title":"Novel fusion KTN1-PRKD1 in cribriform adenocarcinoma of salivary glands located in the parotid gland: case report including cytologic findings","volume":"24","author":"Jassim T","year":"2021","unstructured":"Jassim T, Sheng T, Zhang S, et al.. Novel fusion KTN1-PRKD1 in cribriform adenocarcinoma of salivary glands located in the parotid gland: case report including cytologic findings. Human Pathol Case Rep. 2021, 24:200496. 10.1016\/j.ehpc.2021.200496","journal-title":"Human Pathol Case Rep"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23122","article-title":"A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland","volume":"62","author":"de Jager VD","year":"2023","unstructured":"de Jager VD, de Visscher SA, Schuuring E, Doff JJ, van Kempen LC. A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland. Genes Chromosomes Cancer. 2023, 62:297-300. 10.1002\/gcc.23122","journal-title":"Genes Chromosomes Cancer"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001431","article-title":"Histologic classification and molecular signature of polymorphous adenocarcinoma (PAC) and cribriform adenocarcinoma of salivary gland (CASG): an international interobserver study","volume":"44","author":"Xu B","year":"2020","unstructured":"Xu B, Barbieri AL, Bishop JA, et al.. Histologic classification and molecular signature of polymorphous adenocarcinoma (PAC) and cribriform adenocarcinoma of salivary gland (CASG): an international interobserver study. Am J Surg Pathol. 2020, 44:545-52. 10.1097\/PAS.0000000000001431","journal-title":"Am J Surg Pathol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2020.09.011","article-title":"Polymorphous adenocarcinoma","volume":"14","author":"Katabi N","year":"2021","unstructured":"Katabi N, Xu B. Polymorphous adenocarcinoma. Surg Pathol Clin. 2021, 14:127-36. 10.1016\/j.path.2020.09.011","journal-title":"Surg Pathol Clin"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25266","article-title":"Polymorphous low-grade adenocarcinoma of the head and neck: a population-based study of 460 cases","volume":"125","author":"Patel TD","year":"2015","unstructured":"Patel TD, Vazquez A, Marchiano E, Park RC, Baredes S, Eloy JA. Polymorphous low-grade adenocarcinoma of the head and neck: a population-based study of 460 cases. Laryngoscope. 2015, 125:1644-9. 10.1002\/lary.25266","journal-title":"Laryngoscope"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.39","article-title":"Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience","volume":"136","author":"Seethala RR","year":"2010","unstructured":"Seethala RR, Johnson JT, Barnes EL, Myers EN. Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience. Arch Otolaryngol Head Neck Surg. 2010, 136:385-92. 10.1001\/archoto.2010.39","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8853649","article-title":"Polymorphous adenocarcinoma: a rare case report with unique radiographic appearance on CBCT","volume":"2021","author":"Chandra J","year":"2021","unstructured":"Chandra J, Ahmed J, Veena KM, Vijayakumar M, Shenoy N, Sujir N. Polymorphous adenocarcinoma: a rare case report with unique radiographic appearance on CBCT. Case Rep Dent. 2021, 2021:8853649. 10.1155\/2021\/8853649","journal-title":"Case Rep Dent"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22195","article-title":"Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin","volume":"53","author":"Weinreb I","year":"2014","unstructured":"Weinreb I, Zhang L, Tirunagari LM, et al.. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin. Genes Chromosomes Cancer. 2014, 53:845-56. 10.1002\/gcc.22195","journal-title":"Genes Chromosomes Cancer"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R500002200","article-title":"Protein kinase D signaling","volume":"280","author":"Rozengurt E","year":"2005","unstructured":"Rozengurt E, Rey O, Waldron RT. Protein kinase D signaling. J Biol Chem. 2005, 280:13205-8. 10.1074\/jbc.R500002200","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(03)00487-3","article-title":"Protein kinase D: a family affair","volume":"546","author":"Rykx A","year":"2003","unstructured":"Rykx A, De Kimpe L, Mikhalap S, Vantus T, Seufferlein T, Vandenheede JR, Van Lint J. Protein kinase D: a family affair. FEBS Lett. 2003, 546:81-6. 10.1016\/s0014-5793(03)00487-3","journal-title":"FEBS Lett"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21959","article-title":"The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA","volume":"126","author":"Andreasen S","year":"2018","unstructured":"Andreasen S, Melchior LC, Kiss K, et al.. The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA. Cancer Cytopathol. 2018, 126:275-81. 10.1002\/cncy.21959","journal-title":"Cancer Cytopathol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.115.10.2031","article-title":"Integrin clustering induces kinectin accumulation","volume":"115","author":"Tran H","year":"2002","unstructured":"Tran H, Pankov R, Tran SD, Hampton B, Burgess WH, Yamada KM. Integrin clustering induces kinectin accumulation. J Cell Sci. 2002, 115:2031-40. 10.1242\/jcs.115.10.2031","journal-title":"J Cell Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi H","year":"2018","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018, 18:533-48. 10.1038\/s41568-018-0038-z","journal-title":"Nat Rev Cancer"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1177\/1947601912473479","article-title":"PP2A counterbalances phosphorylation of pRb and mitotic proteins by multiple CDKs: potential implications for PP2A disruption in cancer","volume":"3","author":"Kurimchak A","year":"2012","unstructured":"Kurimchak A, Gra\u00f1a X. PP2A counterbalances phosphorylation of pRb and mitotic proteins by multiple CDKs: potential implications for PP2A disruption in cancer. Genes Cancer. 2012, 3:739-48. 10.1177\/1947601912473479","journal-title":"Genes Cancer"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1593\/neo.06139","article-title":"Fusion of the tumor-suppressor gene CHEK2 and the gene for the regulatory subunit B of protein phosphatase 2 PPP2R2A in childhood teratoma","volume":"8","author":"Jin Y","year":"2006","unstructured":"Jin Y, Mertens F, Kullendorff CM, Panagopoulos I. Fusion of the tumor-suppressor gene CHEK2 and the gene for the regulatory subunit B of protein phosphatase 2 PPP2R2A in childhood teratoma. Neoplasia. 2006, 8:413-8. 10.1593\/neo.06139","journal-title":"Neoplasia"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00696-4","article-title":"Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners","volume":"34","author":"Fritchie K","year":"2021","unstructured":"Fritchie K, Wang L, Yin Z, et al.. Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners. Mod Pathol. 2021, 34:584-91. 10.1038\/s41379-020-00696-4","journal-title":"Mod Pathol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.12.7.17008","article-title":"Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma","volume":"12","author":"Bell D","year":"2011","unstructured":"Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011, 12:569-73. 10.4161\/cbt.12.7.17008","journal-title":"Cancer Biol Ther"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.01.009","article-title":"Adenoid cystic carcinoma: a rare clinical entity and literature review","volume":"47","author":"Gondivkar SM","year":"2011","unstructured":"Gondivkar SM, Gadbail AR, Chole R, Parikh RV. Adenoid cystic carcinoma: a rare clinical entity and literature review. Oral Oncol. 2011, 47:231-6. 10.1016\/j.oraloncology.2011.01.009","journal-title":"Oral Oncol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.4137\/CMO.S34537","article-title":"Mechanisms behind the resistance to trastuzumab in HER2-amplified breast cancer and strategies to overcome it","volume":"10","author":"Luque-Cabal M","year":"2016","unstructured":"Luque-Cabal M, Garc\u00eda-Teijido P, Fern\u00e1ndez-P\u00e9rez Y, S\u00e1nchez-Lorenzo L, Palacio-V\u00e1zquez I. Mechanisms behind the resistance to trastuzumab in HER2-amplified breast cancer and strategies to overcome it. Clin Med Insights Oncol. 2016, 10:21-30. 10.4137\/CMO.S34537","journal-title":"Clin Med Insights Oncol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693394","article-title":"HER2 positivity in histological subtypes of salivary gland carcinoma: a systematic review and meta-analysis","volume":"11","author":"Egebjerg K","year":"2021","unstructured":"Egebjerg K, Harwood CD, Woller NC, Kristensen CA, Mau-S\u00f8rensen M. HER2 positivity in histological subtypes of salivary gland carcinoma: a systematic review and meta-analysis. Front Oncol. 2021, 11:693394. 10.3389\/fonc.2021.693394","journal-title":"Front Oncol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2016.11.004","article-title":"Salivary gland tumors: current concepts and controversies","volume":"10","author":"Seethala RR","year":"2017","unstructured":"Seethala RR. Salivary gland tumors: current concepts and controversies. Surg Pathol Clin. 2017, 10:155-76. 10.1016\/j.path.2016.11.004","journal-title":"Surg Pathol Clin"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31821e1f54","article-title":"Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity","volume":"35","author":"Skalova A","year":"2011","unstructured":"Skalova A, Sima R, Kaspirkova-Nemcova J, et al.. Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol. 2011, 35:1168-76. 10.1097\/PAS.0b013e31821e1f54","journal-title":"Am J Surg Pathol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/his.12883","article-title":"Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland","volume":"68","author":"Piscuoglio S","year":"2016","unstructured":"Piscuoglio S, Fusco N, Ng CK, et al.. Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland. Histopathology. 2016, 68:1055-62. 10.1111\/his.12883","journal-title":"Histopathology"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000980","article-title":"The role of molecular testing in the differential diagnosis of salivary gland carcinomas","volume":"42","author":"Sk\u00e1lov\u00e1 A","year":"2018","unstructured":"Sk\u00e1lov\u00e1 A, Stenman G, Simpson RH, et al.. The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol. 2018, 42:e11-27. 10.1097\/PAS.0000000000000980","journal-title":"Am J Surg Pathol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.03.020","article-title":"Genetic interactions in cancer progression and treatment","volume":"145","author":"Ashworth A","year":"2011","unstructured":"Ashworth A, Lord CJ, Reis-Filho JS. Genetic interactions in cancer progression and treatment. Cell. 2011, 145:30-8. 10.1016\/j.cell.2011.03.020","journal-title":"Cell"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/239618-genetic-rearrangements-in-different-salivary-gland-tumors-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T10:46:37Z","timestamp":1717497997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/239618-genetic-rearrangements-in-different-salivary-gland-tumors-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.61639","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}